Andisten SR
Antisten MV contains Trimetazidine, which is primarily used to support heart health and improve myocardial function. It helps in the management of angina pectoris by optimizing energy metabolism of the heart muscle. By preserving high-energy phosphate levels, it enhances the heart's tolerance to ischemia. Antisten MV is beneficial for patients with stable angina, reducing the frequency of attacks and the need for additional medication. This tablet formulation is convenient for ongoing use, ensuring consistent therapeutic effects. Its cardioprotective properties make it a crucial medication for maintaining cardiovascular health.Active substance:
Trimetazidine dihydrochloridePharmachologic effect:
Antisten MV is a metabolic agent that improves myocardial glucose utilization through inhibition of fatty acid metabolism. It helps maintain energy metabolism of heart and neurosensory tissues during episodes of ischemia.Indications:
- Stable angina pectoris
- Vertigo
- Tinnitus
- Visual disturbances of vascular origin
Contraindications:
- Hypersensitivity to trimetazidine or any of the excipients
- Parkinson's disease
- Movement disorders
- Severe renal impairment
Side effects:
In order of decreasing probability: Nausea, Vomiting, Dizziness, Headache, Abdominal pain, Diarrhea, Rash, Pruritus, Asthenia
Dosing and Administration:
The recommended dose is one tablet of Antisten MV 35 mg twice daily, in the morning and evening, during meals. The dosage may be adjusted based on the patient's condition and response to treatment.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Andisten SR
in Cyrillic : Антистен МВ
SUBSTANCE
Trimetazidine
DOSAGE FORM
tablets
